IRIS Institutional Research Information System - OPENBS Open Archive UniBS

NODARI, Savina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.762
EU - Europa 14.665
AS - Asia 7.091
AF - Africa 51
Continente sconosciuto - Info sul continente non disponibili 32
SA - Sud America 27
OC - Oceania 25
AN - Antartide 1
Totale 43.654
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.685
UA - Ucraina 5.224
CN - Cina 4.886
IT - Italia 3.054
DE - Germania 2.005
HK - Hong Kong 1.159
FI - Finlandia 986
IN - India 789
IE - Irlanda 788
PL - Polonia 768
GB - Regno Unito 751
FR - Francia 618
SE - Svezia 310
TR - Turchia 128
CA - Canada 71
BE - Belgio 56
SG - Singapore 56
MU - Mauritius 41
EU - Europa 31
VN - Vietnam 26
AU - Australia 22
NL - Olanda 17
ES - Italia 16
RU - Federazione Russa 16
BR - Brasile 14
CH - Svizzera 14
AT - Austria 8
IR - Iran 8
RO - Romania 8
TH - Thailandia 7
ID - Indonesia 6
SA - Arabia Saudita 6
TN - Tunisia 5
JP - Giappone 4
SK - Slovacchia (Repubblica Slovacca) 4
CL - Cile 3
CO - Colombia 3
DK - Danimarca 3
IQ - Iraq 3
NZ - Nuova Zelanda 3
PE - Perù 3
ZA - Sudafrica 3
BG - Bulgaria 2
CZ - Repubblica Ceca 2
EC - Ecuador 2
GR - Grecia 2
HU - Ungheria 2
IL - Israele 2
JM - Giamaica 2
LU - Lussemburgo 2
MX - Messico 2
MY - Malesia 2
PH - Filippine 2
UZ - Uzbekistan 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
AZ - Azerbaigian 1
BD - Bangladesh 1
EE - Estonia 1
EG - Egitto 1
FK - Isole Falkland (Malvinas) 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HT - Haiti 1
IM - Isola di Man 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MT - Malta 1
NO - Norvegia 1
PT - Portogallo 1
SI - Slovenia 1
TT - Trinidad e Tobago 1
Totale 43.654
Salva come PNG Salva come JPEG
Città #
Jacksonville 3.831
Fairfield 1.967
Chandler 1.942
Woodbridge 1.700
Princeton 1.548
Nanjing 1.409
Ann Arbor 1.244
Wilmington 1.210
Houston 1.172
Hong Kong 1.155
Ashburn 1.132
Cambridge 1.035
Dublin 782
Warsaw 749
Seattle 691
Beijing 671
New York 597
Nanchang 532
Des Moines 376
Hebei 341
Shenyang 314
Milan 263
Changsha 236
Helsinki 230
Jiaxing 227
Tianjin 221
San Diego 181
Kunming 177
Dearborn 164
Rome 147
Verona 144
Jinan 134
Hangzhou 117
Kocaeli 114
Brescia 113
Boardman 71
Lancaster 65
Ningbo 60
San Francisco 59
Zhengzhou 53
Lanzhou 52
Norwalk 51
Shanghai 51
Taizhou 49
Changchun 47
Florence 46
Brussels 43
Napoli 38
Toronto 38
Fuzhou 31
Guangzhou 31
London 30
Catania 29
Pune 29
Haikou 26
Naples 23
Dong Ket 22
Bologna 21
Torino 21
Palermo 20
Redwood City 20
Augusta 19
Washington 19
San Mateo 17
Westminster 17
Auburn Hills 16
Orange 16
Ottawa 16
Taiyuan 14
Leawood 13
Trieste 13
Caserta 12
Padova 12
Bari 11
Nürnberg 11
Canberra 10
Hefei 10
Monmouth Junction 10
Perugia 10
Redmond 10
Genoa 9
Genova 9
Lappeenranta 9
Los Angeles 9
Pescara 9
Bergamo 8
Cutrofiano 8
Lissone 8
Mountain View 8
Schelle 8
Livorno 7
Modena 7
Rozzano 7
Arezzo 6
Cagliari 6
Chicago 6
Dallas 6
Frankfurt am Main 6
Melbourne 6
Monte San Pietro 6
Totale 28.296
Salva come PNG Salva come JPEG
Nome #
Un caso di Sindrome di Bland-White-Garland: origine anomala dell’arteria coronaria sinistra dall’arteria polmonare. 631
Inodilatatori: perché e quali. 362
Il genotipo DD per il gene dell’enzima di conversione dell’angiotensina identifica i pazienti con insufficienza cardiaca che possono beneficiare di dosi medio elevate di ACE inibitori. 277
Relation of serum magnesium levels and postdischarge outcomes in patients hospitalized for heart failure (from the EVEREST Trial) 265
Worsening renal function in patients hospitalised for acute heart failure: Clinical implications and prognostic significance 265
Livelli circolanti del marcatore tumorale CA 125 in pazienti con scompenso cardiaco cronico:relazione con la classe NYHA, i parametri ecocardiografici e variazioni indotte dalla terapia. 241
Valutazione dell’indice di performance miocardica (MPI) del ventricolo destro con studio eco-doppler in pazienti affetti da insufficienza cardiaca. 238
Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. 208
Role of beta1- and alpha2c-adrenergic receptor polymorphisms and their combination in heart failure: a case-control study 203
I polimorfismi Arg16Gly del gene recettore beta-2 adrenergico influenzano i parametri emodinamici e la prognosi dei pazienti con insufficienza cardiaca 194
L’ indice di performance miocardica ( MPI ) è un importante indicatore prognostico nei pazienti affetti da insufficienza cardiaca cronica. 183
Effects of supplementation with polyunsaturated fatty acids in patients with heart failure. 182
I polimorfismi Arg16 Gly del gene recettore beta-2 adrenergico influenzano i parametri emodinamici e la prognosi dei pazienti con insufficienza cardiaca. 178
Valvola aortica quadricuspide asintomatica : un caso clinico. 152
Determinazione dell’equilibrio simpato-vagale attraverso l’analisi spettrale della variabilità della frequenza cardiaca in pazienti con insufficienza cardiaca di diverso grado di severità. 150
Risk of Cardiovascular Hospitalizations from Exposure to Coarse Particulate Matter (PM10) Below the European Union Safety Threshold 149
Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol. 147
Efficacia di un nuovo diuretico, la muzolimina, in pazienti con insufficienza cardiaca. 146
The role of n-3 PUFAs in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathy. 144
Genetic Polymorphisms as Possible Factors Involved in the Onset of Anthracycline-Induced Cardiomyopathy 140
Fattori di rischio ed “epidemiologia inversa” nei pazienti con insufficienza cardiaca. 139
Serum levels of different tumoral markers in patients with congestive heart failure. 131
A randomized double-blind crossover study of nicardipine and nifedipine in patients with angina pectoris and concomitant essential hypertension. 125
Pre-discharge and early post-discharge troponin elevation among patients hospitalized for heart failure with reduced ejection fraction: Findings from the ASTRONAUT trial 122
Acute heart failure syndromes: assessment and reconstructing the heart. 115
Nutritional Supplementation with Amino Acids in Ambulatory Patients with Idiophatic Dilatated Cardiomyophaty 114
Spectrum of epidemiological and clinical findings in patients with heart failure with preserved ejection fraction stratified by study design: a systematic review 114
Prognostic Value of Serial Clinical, Laboratory and Ecocardiographic Tests in Ambulatory Patients with Chronic Heart Failure 113
Are Beta-1 and alpha2c-adrenergic receptor polymorphisms associated with an increased risk of heart failure in Caucasian subjects: results of a case-control study 112
Safety and Tolerability of Neladenoson Bialanate, a Novel Oral Partial Adenosine A1 Receptor Agonist, in Patients with Chronic Heart Failure 112
Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial 110
Effects of aldosterone blockers on left ventricular function and remodeling in patients with mild-moderate chronic heart failure. 109
Raised homocystein plasma concentration in patients with heart failure: Clinical significance 109
The 6-min walking test early after cardiac surgery. Reference values and the effects of rehabilitation programme. 108
Prognostic significance of serum total cholesterol and triglyceride levels in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial) 108
Acute hemodynamic effects of the two dopaminergic agonists ibopamine and dihydroergotamine, a comparison with the parent compound. 107
Angiotensin-converting-enzyme gene polymorphism and heart failure: a case-control study. 107
The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T 107
Asse cuore-rene nell’iperteso cardiopatico. 106
Acute and chronic effects of nisoldipine in patients with chronic heart failure. 106
Clinical significance of Beta-adrenergic receptor polymorphisms in the patients with chronic heart failure 106
A rationale for the use of BETA-blockers as standard treatment for heart failure 105
Changes in serum potassium levels during hospitalization in patients with worsening heart failure and reduced ejection fraction (from the EVEREST trial) 104
Beta- adrenergic receptors polymorphisms and response to CRT 103
Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial 103
Anemia and heart failure : a cause of progression or only a consequence? 101
Cardiovascular and non cardiovascular comorbidities in patients with chronic heart failure. 100
n-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective, randomized study. 100
Effects of Polyunsaturated Fatty Acid Treatment on Postdischarge Outcomes After Acute Myocardial Infarction 98
Combination decongestion therapy in hospitalized heart failure: loop diuretics, mineralocorticoid receptor antagonists and vasopressin antagonists 98
Rest and exercise effects of the acute and chronic administration of nisoldipine in patients with heart failure. 97
Abnormal hemodynamics and ventilatory response to exercise may identify chronic heart failure patients at high risk despite long term beta-blocker treatment. 96
Lack of association of coeliac disease with idiopathic and ischaemic dilated cardiomyopathies. 96
Independent role of resting heart rate at discharge as a predictor of mortality after hospitalisation for acute heart failure. 96
Effects of oral amino Acid supplements on functional capacity in patients with chronic heart failure. 96
Predicting heart failure outcome from cardiac and comorbid conditions: the 3C-HF score 96
Influence of the angiotensin-converting enzyme genotype on the response to the beta-blocker therapy and the prognosis of the patients with chronic heart failure. 95
Clinical trials update from the World Congress of Cardiology 2006. 95
Usefulness of cardiac calcification on two-dimensional echocardiography for distinguishing ischaemic from nonischaemic dilated cardiomyopathy: a preliminary report. 95
Improved graft patency rates and mid-term outcome of diabetic patients undergoing total arterial myocardial revascularization. 94
A Current treatment in acute and chronic cardio-renal syndrome. 93
Six-year prognosis of diabetic patients with coronary artery disease. 92
Effects of oral administration of orodispersible levo-carnosine on quality of life and exercise performance in patients with chronic heart failure. 92
Maximal and submaximal exercise testing in heart failure. 92
Different prognostic values of clinical and metabolic parameters in ischaemic diabetic patients with preserved/impaired left ventricular function. 91
Efficacy and tolerability of the long-term administration of carvedilol in patients with chronic heart failure with and without concomitant diabetes mellitus. 91
Tako-tsubo-like left ventricular dysfunction: transient left ventricular apical ballooning syndrome 91
Identification, prevention and management of cardiovascular risk in chronic myeloid leukaemia patients candidate to ponatinib: an expert opinion 91
Acute heart failure with low cardiac output: can we develop a short-term inotropic agent that does not increase adverse events? 91
Ibopamine treatment in dopamine dependent heart failure: purpose of a new treatment scheme. 90
Beta-1 adrenoceptor gene polimorphism in heart failure: clinical and prognostic significance in female patients. 90
Response to the letter of Hester Den Ruijter and Ruben Coronel regarding the article "the role of n-3 pufas in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathy" 90
Redefining biomarkers in heart failure 89
The Prevention of Sudden Death: New Perspectives. 88
Managing heart failure in the very old 87
Ruolo prognostico della fibrinogemia in pazienti diabetici ricoverati per sindrome coronarica acuta. 87
Role of fluid retention in patients hospitalised for acute heart failure. 87
Prediction of 1-year outcomes after an acute heart failure hospitalisation: importance of variables measured at the time of discharge. 87
Weight loss favorably affects the cardiac sympatho-vagal balance of the obese patients: results of power spectral analysis of heart rate variability. 86
CA 125 Tumoral Marker Plasma Levels Relate to systolic and Diastolic Ventricular Function and to the Clinical Status of Patients with Chronic Heart Failure 86
Effects of Spironolactone on Long-term Mortality and Morbidity in Patients With Heart Failure and Mild or No Symptoms. 86
Clinical profile and prognostic value of anemia at the time of admission and discharge among patients hospitalized for heart failure with reduced ejection fraction: findings from the EVEREST trial 86
Betabloccanti e sopravvivenza: risultati diversi per farmaci diversi? I risultati dello studio COMET 86
Use of cardiopulmonary exercise testing with hemodynamic monitoring in the prognostic assessment of ambulatory patients with chronic heart failure 86
Is total arterial myocardial revascularization with composite grafts a safe and useful procedure in the elderly? 85
Clinical significance of beta-adrenergic receptor polymorphisms in the patients with chronic heart failure. 84
The role of beta blockade in heart failure 84
Pharmacological activity of the new calcium antagonist, lacidipine, on isolated preparations. 84
Biventricular cardiac resynchronization in moderate-to-severe heart failure: Analysis of hospital costs and clinical effectiveness (Brescia study) 84
Asymptomatic quadricuspid aortic valve. 84
Role of worsening renal function in patients hospitalised for acute heart failure 83
Beta-1 adrenergic receptor gene polimorphism in heart failure: a gender specific clinical and prognostic role? 83
Mediterranean diet impact on cardiovascular diseases: A narrative review 83
Lack of tolerance development during chronic ibopamine administration to patients with congestive heart failure. 82
Plasma homocysteine levels and late outcome in patients with unstable angina. 82
Off-pump coronary artery bypass surgery technique for total arterial myocardial revascularization: a prospective randomized study. 82
Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions 82
Prognostic variables in patients hospitalised for acute heart failure: a single center experience. 81
Combined invasive and noninvasive study of left ventricular systolic and diastolic function following acute administration of cicloprolol to subjects with normal cardiac function 81
Integrated heart failure management in the patient with heart failure caused by left ventricular systolic dysfunction. 81
Totale 12.163
Salva come PNG Salva come JPEG
Categoria #
all - tutte 190.545
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 190.545
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.488 0 0 0 0 0 0 0 0 0 308 581 599
2019/202010.916 2.436 204 259 1.187 314 1.237 764 1.198 571 1.454 383 909
2020/20218.074 97 1.062 177 989 148 1.054 231 1.058 1.662 521 921 154
2021/20225.003 136 1.082 50 343 83 252 151 371 290 647 522 1.076
2022/20235.500 851 61 48 516 513 1.618 16 565 854 44 192 222
2023/20243.197 332 101 173 234 145 738 121 110 1.205 38 0 0
Totale 44.177